Cargando…

Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia

SIMPLE SUMMARY: Head and neck cancer patients face significant morbidity and mortality. Early detection and diagnosis of disease followed by timely intervention is necessary for improving clinical management for these patients. There remains a need to be able to identify whether an early pre-cancero...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranganath, Kushi, Feng, Allen L., Franco, Ramon A., Varvares, Mark A., Faquin, William C., Naunheim, Matthew R., Saladi, Srinivas Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688631/
https://www.ncbi.nlm.nih.gov/pubmed/36428690
http://dx.doi.org/10.3390/cancers14225581
_version_ 1784836318304403456
author Ranganath, Kushi
Feng, Allen L.
Franco, Ramon A.
Varvares, Mark A.
Faquin, William C.
Naunheim, Matthew R.
Saladi, Srinivas Vinod
author_facet Ranganath, Kushi
Feng, Allen L.
Franco, Ramon A.
Varvares, Mark A.
Faquin, William C.
Naunheim, Matthew R.
Saladi, Srinivas Vinod
author_sort Ranganath, Kushi
collection PubMed
description SIMPLE SUMMARY: Head and neck cancer patients face significant morbidity and mortality. Early detection and diagnosis of disease followed by timely intervention is necessary for improving clinical management for these patients. There remains a need to be able to identify whether an early pre-cancerous lesion at the dysplasia stage will progress to invasive cancer. Biomarkers are biological molecules found in blood or tissue that are measurable at early stages of disease and can be applied to predict the progression of such lesions. The aim of this review is to comprehensively present the available evidence on the most frequently altered tumor molecular biomarkers present in head and neck dysplasia as well as their potential clinical applications. ABSTRACT: Head and neck squamous cell carcinoma (HNSCC) and its treatments are associated with substantial morbidity, often resulting in cosmetic deformity and loss of physiologic functions including speech and swallowing. Despite advancements in treatment, 5-year survival rates for mucosal malignancies remain below 70%. Effective prevention of HNSCC demands an understanding of the molecular pathways of carcinogenesis. Specifically, defining features of pre-cancerous dysplastic lesions that indicate a better or worse prognosis is necessary to help identify patients who are likely to develop a carcinoma and allow a more aggressive approach to management. There remains a need for identification of biomarkers that can provide both early prognostic and predictive value in clinical decision-making by serving as both therapeutic targets as well as predictors of therapy response. Here, we comprehensively review the most frequently altered molecular biomarkers of malignant transformation in head and neck dysplasia. These markers are involved in a wide range of cellular processes in head and neck carcinogenesis, including extracellular matrix degradation, cell motility and invasion, cell–cell adhesion, solute transport, immortalization, metabolism, the cell cycle and apoptosis, transcription, and cell signaling.
format Online
Article
Text
id pubmed-9688631
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96886312022-11-25 Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia Ranganath, Kushi Feng, Allen L. Franco, Ramon A. Varvares, Mark A. Faquin, William C. Naunheim, Matthew R. Saladi, Srinivas Vinod Cancers (Basel) Review SIMPLE SUMMARY: Head and neck cancer patients face significant morbidity and mortality. Early detection and diagnosis of disease followed by timely intervention is necessary for improving clinical management for these patients. There remains a need to be able to identify whether an early pre-cancerous lesion at the dysplasia stage will progress to invasive cancer. Biomarkers are biological molecules found in blood or tissue that are measurable at early stages of disease and can be applied to predict the progression of such lesions. The aim of this review is to comprehensively present the available evidence on the most frequently altered tumor molecular biomarkers present in head and neck dysplasia as well as their potential clinical applications. ABSTRACT: Head and neck squamous cell carcinoma (HNSCC) and its treatments are associated with substantial morbidity, often resulting in cosmetic deformity and loss of physiologic functions including speech and swallowing. Despite advancements in treatment, 5-year survival rates for mucosal malignancies remain below 70%. Effective prevention of HNSCC demands an understanding of the molecular pathways of carcinogenesis. Specifically, defining features of pre-cancerous dysplastic lesions that indicate a better or worse prognosis is necessary to help identify patients who are likely to develop a carcinoma and allow a more aggressive approach to management. There remains a need for identification of biomarkers that can provide both early prognostic and predictive value in clinical decision-making by serving as both therapeutic targets as well as predictors of therapy response. Here, we comprehensively review the most frequently altered molecular biomarkers of malignant transformation in head and neck dysplasia. These markers are involved in a wide range of cellular processes in head and neck carcinogenesis, including extracellular matrix degradation, cell motility and invasion, cell–cell adhesion, solute transport, immortalization, metabolism, the cell cycle and apoptosis, transcription, and cell signaling. MDPI 2022-11-15 /pmc/articles/PMC9688631/ /pubmed/36428690 http://dx.doi.org/10.3390/cancers14225581 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ranganath, Kushi
Feng, Allen L.
Franco, Ramon A.
Varvares, Mark A.
Faquin, William C.
Naunheim, Matthew R.
Saladi, Srinivas Vinod
Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia
title Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia
title_full Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia
title_fullStr Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia
title_full_unstemmed Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia
title_short Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia
title_sort molecular biomarkers of malignant transformation in head and neck dysplasia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688631/
https://www.ncbi.nlm.nih.gov/pubmed/36428690
http://dx.doi.org/10.3390/cancers14225581
work_keys_str_mv AT ranganathkushi molecularbiomarkersofmalignanttransformationinheadandneckdysplasia
AT fengallenl molecularbiomarkersofmalignanttransformationinheadandneckdysplasia
AT francoramona molecularbiomarkersofmalignanttransformationinheadandneckdysplasia
AT varvaresmarka molecularbiomarkersofmalignanttransformationinheadandneckdysplasia
AT faquinwilliamc molecularbiomarkersofmalignanttransformationinheadandneckdysplasia
AT naunheimmatthewr molecularbiomarkersofmalignanttransformationinheadandneckdysplasia
AT saladisrinivasvinod molecularbiomarkersofmalignanttransformationinheadandneckdysplasia